v3.26.1
Unaudited Condensed Consolidated Interim Statements of Changes in Stockholders’ Deficit - USD ($)
$ in Thousands
Preferred Stock
Common Stock
Additional paid-in capital
Accumulated deficit
Accumulated Other Comprehensive Income
Non-controlling interest
Total
Balance (in Shares) at Dec. 31, 2024 0 39,444 [1]          
Balance at Dec. 31, 2024 $ 0 [2] $ 37,760 $ (201,076) $ (34) $ 0 $ (163,350)
Issuance of common stock from exercise of pre-funded warrants (in Shares) [1]   667          
Issuance of common stock from exercise of pre-funded warrants   [2] 3,056       3,056
Stock-based compensation     178       178
Foreign currency translation adjustments         (59)   (59)
Comprehensive income (loss) for the period       102,958     102,958
Balance (in Shares) at Mar. 31, 2025 0 40,111 [1]          
Balance at Mar. 31, 2025 $ 0 $ 0 [2] 40,994 (98,118) (93) 0 (57,217)
Balance (in Shares) at Dec. 31, 2024 0 39,444 [1]          
Balance at Dec. 31, 2024 $ 0 [2] 37,760 (201,076) (34) 0 (163,350)
Comprehensive income (loss) for the period             105,977
Balance (in Shares) at Jun. 30, 2025 0 42,967 [1]          
Balance at Jun. 30, 2025 $ 0 $ 0 [2] 41,932 (95,099) (216) 0 (53,383)
Balance (in Shares) at Mar. 31, 2025 0 40,111 [1]          
Balance at Mar. 31, 2025 $ 0 $ 0 [2] 40,994 (98,118) (93) 0 (57,217)
Issuance of common stock in relation to settlement agreement   $ 0 [2] 157       157
Issuance of common stock in relation to settlement agreement (in Shares) [1]   100          
Issuance of common stock in relation to conversion of note into equity   $ 0 [2] 781       781
Issuance of common stock in relation to conversion of note into equity (in Shares) [1]   2,082          
Issuance of common stock from exercise of options [2]   $ 0 0        
Issuance of common stock from exercise of options (in Shares) [1]   674          
Foreign currency translation adjustments         (123)   (123)
Comprehensive income (loss) for the period       3,019     3,019
Balance (in Shares) at Jun. 30, 2025 0 42,967 [1]          
Balance at Jun. 30, 2025 $ 0 $ 0 [2] 41,932 (95,099) (216) 0 (53,383)
Balance (in Shares) at Dec. 31, 2025 0 152,206 [1]          
Balance at Dec. 31, 2025 $ 0 $ 2 102,737 (122,527) 0 4,209 (15,579)
Issuance of common stock from exercise of warrants (in Shares) [1]   27,871          
Issuance of common stock from exercise of warrants   $ 0 [2] 4,960 0     4,960
Stock-based compensation (in Shares) [1]   3,800          
Stock-based compensation   $ 0 [2] 1,907 0     1,907
Issuance of common stock in relation to private placement (in Shares) [1]   19,512          
Issuance of common stock in relation to private placement   $ 0 [2] 0 [2] 0     0 [2]
Issuance of preferred stock in relation to private placement (in Shares) 200 0 [1]          
Issuance of preferred stock in relation to private placement     0        
Issuance of common stock for purchase of subsidiaries (in Shares) [1]   52,963          
Issuance of common stock for purchase of subsidiaries   $ 1 24,902 0     24,903
Issuance of common stock in relation to conversion of note into equity   $ 0 [2] 3,153 0     3,153
Issuance of common stock in relation to conversion of note into equity (in Shares) [1]   13,000          
Equity classified warrants issued as part of purchase of subsidiaries     45,646 0     45,646
Shares issued as penalty (in Shares) [1]   585          
Shares issued as penalty   $ 0 [2] 0 0     0 [2]
Shares issued to settle commitment under ELOC agreement (in Shares) [1]   2,439          
Shares issued to settle commitment under ELOC agreement   $ 0 [2] 0 0     0 [2]
Issuance of shares from ELOC exercises (in Shares) [1]   31,745          
Issuance of shares from ELOC exercises   $ 1 3,529 0     3,530
Issuance of shares for settlement of debt on related party (in Shares) [1]   1,600          
Issuance of shares for settlement of debt on related party   $ 0 [2] 300 0     300
Subsidiary consolidation for the first time     0   (139) 1,739 1,600
Accretion of noncontrolling interests subject to possible redemption     (1,275) 0   (514) (1,789)
Foreign currency translation adjustments     0 0 115 128 243
Comprehensive income (loss) for the period     0 (27,147)   796 (26,351)
Balance (in Shares) at Mar. 31, 2026 200 305,721 [1]          
Balance at Mar. 31, 2026 $ 0 $ 4 185,859 (149,674) (24) 6,358 42,523
Balance (in Shares) at Dec. 31, 2025 0 152,206 [1]          
Balance at Dec. 31, 2025 $ 0 $ 2 102,737 (122,527) 0 4,209 $ (15,579)
Shares issued to settle commitment under ELOC agreement (in Shares)             14,800
Comprehensive income (loss) for the period             $ (107,780)
Balance (in Shares) at Jun. 30, 2026 200 758,660 [1]          
Balance at Jun. 30, 2026 $ 0 $ 10 207,104 (232,162) (276) 5,665 (19,659)
Balance (in Shares) at Mar. 31, 2026 200 305,721 [1]          
Balance at Mar. 31, 2026 $ 0 $ 4 185,859 (149,674) (24) 6,358 42,523
Issuance of common stock from exercise of warrants (in Shares) [1]   211,544          
Issuance of common stock from exercise of warrants   $ 3 12,795       12,798
Issuance of common stock in connection with the VisionWave share exchange (in Shares) [1]   48,000          
Issuance of common stock in connection with the VisionWave share exchange   $ 1 2,353       2,354
Issuance of common stock in relation to conversion of note into equity     2,139       2,139
Issuance of common stock in relation to conversion of note into equity (in Shares) [1]   33,395          
Issuance of shares from ELOC exercises (in Shares) [1]   160,000          
Issuance of shares from ELOC exercises   $ 2 4,541       4,543
Transaction with non-controlling interests and deconsolidation of subsidiary     358     (1,140) (782)
Accretion of noncontrolling interests subject to possible redemption     (941)     (380) (1,321)
Foreign currency translation adjustments         (252) (231) (483)
Comprehensive income (loss) for the period       (82,488)   1,058 (81,430)
Balance (in Shares) at Jun. 30, 2026 200 758,660 [1]          
Balance at Jun. 30, 2026 $ 0 $ 10 $ 207,104 $ (232,162) $ (276) $ 5,665 $ (19,659)
[1] Share amounts have been retroactively adjusted to reflect the 1-for-125 Reverse Stock Split (see Note 1).
[2] Less than $1 thousand.